-+ 0.00%
-+ 0.00%
-+ 0.00%

Raymond James Initiates Coverage On Benitec Biopharma with Outperform Rating, Announces Price Target of $14

Benzinga·10/23/2026 11:10:54
语音播报
Raymond James analyst Tiago Fauth initiates coverage on Benitec Biopharma (NASDAQ:BNTC) with a Outperform rating and announces Price Target of $14.